Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Thursday's Exclusive Content Oklo: The Bottom Is In, and the Upside Potential Is NuclearSubmitted by Thomas Hughes. Originally Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profits, but that hasn't dented investor enthusiasm. Its fiscal year 2025 (FY2025) progress report and updates show the company is on track to meet long-term goals and market expectations. The market response — including analyst updates following the release — makes that clear: near-term revenue is being weighed against a larger long-term opportunity. Analysts Focus on Oklo's Long-Term Opportunity MarketBeat tracked about half a dozen analyst revisions within 12 hours of the release. They included a single price-target reduction, offset by a larger number of affirmed ratings and targets, and no downgrades. Elon Musk Just Called the Dollar "Hopeless" – Then Reinvented It What's going on with Elon Musk? Last year, he launched a full-blown attack on the U.S. dollar, calling it "hopeless." And within months, he hatched a plan to reinvent the world reserve currency. Now, with the blessing of President Trump and the U.S. Treasury, it's coming to life. And investors who grasp what's going on could make a fortune. Full story here. This activity fits the broader trend: increasing coverage, a steady Moderate Buy rating, a 58% buy-side bias, and rising price targets. Those targets are a critical factor — consensus implies more than 50% upside relative to mid‑March lows. While analysts expressed concern about the 2025 results, their focus remains on the long-term opportunity and progress with Nuclear Regulatory Commission licensing. The company received its first license, awarded to its subsidiary Atomic Alchemy, which produces isotopes. The license permits the receipt, possession, storage, processing, repackaging, and distribution of up to two curies of radium‑226 — roughly two grams. Two grams isn't much, and radium‑226 alone isn't particularly valuable. It was once used in medical applications but now is costly to handle and remediate. Demand is rising, however, because radium‑226 is a precursor for actinium, a high‑value element used in specialized cancer treatments that can cost roughly $20,000 per dose. The takeaway for investors is that Oklo's diversification strategy has been validated and a potential revenue stream has been opened. It may take a few quarters for meaningful revenue to materialize, but that is likely to occur well before the commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Reveal the Bottom is In for Oklo Stock Institutional and short-selling data point toward a bottom for Oklo stock. Short interest remains high — about 15% as of early March — but it has declined from its peak around Oklo's October 2025 highs and is likely to fall further in upcoming reports. Institutional activity moved the other direction: buying accelerated after Oklo's Q2 2025 plunge and reached record highs in early 2026.  As it stands, institutions own roughly 85% of the stock, providing solid support and accumulating at about $3 bought for every $1 sold. If these trends continue, the number of freely available shares could shrink significantly over the coming months, supporting higher prices — and a catalyzing news event could trigger a short squeeze. Dilutive Headwinds Cease in 2026 Shareholder dilution was significant in 2025 but should ease in 2026. The company's share count is roughly 50% higher year over year, and its balance sheet appears well capitalized. FY2026 plans indicate sufficient capital to fund operations for about two years at the current burn rate, giving secondary revenue streams, such as the isotope business, time to mature. The trade-off is that profitability isn't expected until 2030, so additional capital may be required further down the road. The technical setup also looks constructive. OKLO's stock is well off its highs and appeared oversold at March levels. The MACD has diverged and turned bullish, and the stochastic has followed suit, signaling a strong buy at current levels. The open question is whether the market will follow through on those signals — it may take time to gain traction — and the lack of revenue and profits remains a heavy weight for any market to lift. The biggest risk is execution delays. The market is pricing in a robust growth outlook — valuing the stock at more than 100x first‑year earnings — and may not be patient with setbacks. That leaves Oklo exposed to volatility whether the rebound begins sooner or later. | 
